O-1602
O-1602 is an agonist of GPR55 (G protein-coupled receptor 55) . O-1602 reduces the number and activation of hippocampal microglia induced by METH (methamphetamine) . O-1602 decreases the expression levels of NLRP3 inflammasome proteins, including NLRP3, ASC and Caspase-1[1].
Product Specifications
CAS Number
317321-41-8
UNSPSC
12352005
Hazard Statement
H225, H319, H336
Target
GPR55
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/o-1602.html
Concentration
10mM
Purity
99.68
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC1=C([C@H]2[C@@H](CCC(C)=C2)C(C)=C)C(O)=CC(O)=C1
Molecular Formula
C17H22O2
Molecular Weight
258.36
Precautions
H225, H319, H336
References & Citations
[1]Jinlong Zhang, et al. GPR55 activation improves anxiety- and depression-like behaviors of mice during methamphetamine withdrawal.Heliyon, 10 (2024), e30462.|[2]A. Díaz-Arteaga, et al. The atypical cannabinoid O-1602 stimulates food intake and adiposity in rats. Diabetes, Obesity and Metabolism. March 2012, Volume14, Issue3.|[3]Peng Ma, et al. IAVPGEVA: Orally Available DPP4-Targeting Soy Glycinin Derived Octapeptide with Therapeutic Potential in Nonalcoholic Steatohepatitis.Journal of Agricultural and Food Chemistry. 2024, 72, 13, 7167–7178.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC472862-100 1x 100 µL
HLA-DP (MHC II) (HLA-DPB1/2862R), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
